Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Yishengyuan Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Shanghai, China, established in 2001. The company specializes in the production of a diverse range of pharmaceutical dosage forms, including tablets, granules, oral solutions, and active pharmaceutical ingredients (APIs). Its commercial portfolio features generic drugs such as Sulpiride for psychiatric disorders, Oxaprozin for pain and inflammation, and Benserazide hydrochloride for Parkinson's disease. Additionally, the company produces traditional Chinese medicine (TCM) formulations and is licensed for the production of anti-tumor oral solutions. Operating from its facility in the Pudong New Area, Shanghai Yishengyuan serves the healthcare market through the manufacture of both chemical and herbal medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Yishengyuan Pharmaceutical.